Wedbush has recently initiated Vor Biopharma Inc (VOR) stock to Outperform rating, as announced on July 26, 2022, according to Finviz. Earlier, on April 27, 2022, Goldman had initiated the stock to ...
Fintel reports that on January 3, 2025, Wedbush upgraded their outlook for PulteGroup (NYSE:PHM) from Neutral to Outperform.
Nvidia became the leader in market capitalisation gains for 2024, driven by AI demand, boosting its value to $3.28 trillion.
As previously reported, Wedbush analyst Jay McCanless upgraded PulteGroup (PHM) to Outperform from Neutral with a $135 price target arguing ...
Wedbush upgraded PulteGroup (PHM) to Outperform from Neutral with a $135 price target Don't Miss Our New Year's Offers:Discover the latest ...
Richard Anderson from Wedbush has set a price target of $70 for BXP (NYSE:BXP), indicating a potential downside from its ...
Fintel reports that on January 2, 2025, Wedbush upgraded their outlook for VICI Properties (NYSE:VICI) from Neutral to ...
Tesla’s global annual sales have fallen for the first time in more than a dozen years. It's a blow to a stock that has soared ...
Increased competition and concern from buyers about the price of electric vehicles means lower-than-average sales for the US ...
The "seeds" that will shape Apple's "end customer growth narrative" in the coming years are currently visible. Wedbush ...